Serplulimab

product
1 mentions 1 recordings first heard Nov 2025 last heard 17 Nov ↑1 vs the 12 months before

Serplulimab is a PD-1 checkpoint inhibitor developed by Fosun Pharma, used in lung cancer.

Trend

mentions per week · public audio 7d30d6M12M
1 · 14 Nov SepDecMarJunnow

Peak in the week of 14 Nov — 1 mentions across 1 series.

Moments

newest first · ▶ plays the moment
Sam FazeliVanguards of Healthcare by Bloomberg Intelligence · Fosun Pharma’s Drive Beyond China · 21:31 · 17 Nov
…One of my favorite in the Henleus Fosun Pharma world is Serplulimab.…
· Open transcript →
All 1 moments